//
sign in
Profile
by @danabra.mov
Profile
by @dansshadow.bsky.social
Profile
by @jimpick.com
AviHandle
by @danabra.mov
AviHandle
by @dansshadow.bsky.social
AviHandle
by @katherine.computer
EventsList
by @katherine.computer
ProfileHeader
by @dansshadow.bsky.social
ProfileHeader
by @danabra.mov
ProfileMedia
by @danabra.mov
ProfilePlays
by @danabra.mov
ProfilePosts
by @danabra.mov
ProfilePosts
by @dansshadow.bsky.social
ProfileReplies
by @danabra.mov
Record
by @atsui.org
Skircle
by @danabra.mov
StreamPlacePlaylist
by @katherine.computer
+ new component
Profile
Loading...
Neuro-Oncologist at Memorial Sloan Kettering Cancer Center, Health Disparities Researcher
Joshua Budhu









Loading...
Excited to share our new @aanmember.bsky.social Position Statement: A Roadmap to Neurologic Health Equity, outlining actionable steps to move from recognizing disparities to implementing solutions across care, research, and policy. neurology.org/doi/full/10....
Excited to share our new review in Cancers on sociodemographic disparities and health-related quality of life in adults with gliomas. mdpi.com/2072-6694/18... #NeuroOncology #HealthEquity #BrainTumors
Excited to share our new review on financial toxicity in cancer. We discuss how financial burden arises across multiple levels patients, providers, health systems, and policy and why solutions must extend beyond the individual. tinyurl.com/5htzkrwf @fumikochino.bsky.social @bthomphd.bsky.social
For me, this hits close to home. We’ve seen what happened with lomustine and the impact on brain tumor patients when a life-saving therapy becomes inaccessible. These aren’t abstract policy issues — they have real consequences for people. @eddiecliff.bsky.social @mskcancercenter.bsky.social
Proud of this new @healthaffairs.bsky.social piece: Essential Drugs Must Be Affordable and Accessible. So proud of @cuny.edu Medicine student Merna Shohdy — she did an incredible job breaking down why essential meds remain out of reach for too many patients. www.healthaffairs.org/content/fore...
As neurology enters the era of high-cost therapies, financial toxicity is becoming a key determinant of access, adherence, and equity. Proud to work with superstar resident Dr. Gotlieb on this viewpoint in @greenjournal.bsky.social neurology.org/doi/full/10.... @mskcancercenter.bsky.social
📌 CHPC leadership Dr. Beth McGinty, Dr. Will Schpero, & Weill Cornell Medical student Michael Liu have a piece out in Health Affairs Scholar: "Regional changes in inpatient psychiatric bed capacity and availability of alternative psychiatric services, 2012-2022" 👉 Read here:
2mo
3mo
3mo
7mo
1mo
7mo
6mo
There are steps we can take to improve access to lifesaving drugs for patients, including the ones listed in this Health Affairs post. #pharmacoequity Essential Drugs Must Be Affordable And Accessible www.healthaffairs.org/content/fore... by @jbudhu.bsky.social @eddiecliff.bsky.social
đź’¸ #Financialtoxicity interventions from patient to provider to policy. Ultimately, sustainable solutions must occur at the societal level, where structural reforms in financing, transparency, & consumer protection can promote greater equity & safeguard pt financial well being.
March 4th. The only date that is also a command. It's been 19 years since my husband died of cancer & my life irreversibly changed. It took me years to feel like I wasn't drowning every minute of every day. Grief & financial toxicity gave me a mission. jamanetwork.com/journals/jam...
6mo
3mo
3mo
neurology.org
Neurology® Journals
Joshua Budhu
Joshua Budhu
Joshua Budhu
Joshua Budhu
Joshua Budhu
Joshua Budhu
Cornell Health Policy Center
HealthBegins
Neurologic disorders affect more than 200 million people in the United States, yet inequities in neurologic health persist particularly among marginalized populations. These disparities are rooted not...
neurology.org
A Roadmap to Neurologic Health Equity | Neurology
Fumiko Ladd Chino, MD FASCO
Fumiko Ladd Chino, MD FASCO